Stock Quote
ImaRx Therapeutics, Inc. (IMRX.OB) (OTC BB)
$0.02
27 Nov 2009
-10.53%
$0.02
$0.02
11,000
$0.02
$0.02
$0.04
$0.01
0.32
9,599
IMRX.OB
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Love, Richard | Chairman of the Board | -- |
| Otto, Richard | Director | -- |
| Pew, Thomas | Director | -- |
Profile
ImaRx Therapeutics, Inc. is a development-stage biopharmaceutical company focused on the development of therapies for stroke and other vascular disorders, using its microsphere technology together with ultrasound. The Company’s lead program, SonoLysis, involves the administration of its MRX-801... Full Description
Company Address
ImaRx Therapeutics, Inc.
18116 232nd NE
Woodinville WA 98077
P: +1520.7701259
F: +1520.7912437
18116 232nd NE
Woodinville WA 98077
P: +1520.7701259
F: +1520.7912437
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Genentech, Inc. | -- | -- |
| Paion AG | €2.10 | +0.01 |
| Neurobiological Technologies, Inc. | $0.32 | +0.06 |
| IMRX.OB | Industry | |
|---|---|---|
| P/E(TTM) | -- | 13.11 |
| P/S(TTM) | 0.06 | 32.32 |
| ROI(TTM) | -471.36 | 2.21 |
| ROE(TTM) | -471.36 | 3.47 |
No consensus estimates data available.
| Total Revenue | $0.00M |
| Net Income | $-0.43M |
| EPS | $-0.04 |
